Published in J Biol Chem on January 04, 2002
The ankyrin repeat as molecular architecture for protein recognition. Protein Sci (2004) 5.07
Molecular mechanisms of proteasome assembly. Nat Rev Mol Cell Biol (2009) 2.82
Hexameric assembly of the proteasomal ATPases is templated through their C termini. Nature (2009) 1.97
Multiple assembly chaperones govern biogenesis of the proteasome regulatory particle base. Cell (2009) 1.85
Assembly, structure, and function of the 26S proteasome. Trends Cell Biol (2010) 1.61
Thioredoxin Txnl1/TRP32 is a redox-active cofactor of the 26 S proteasome. J Biol Chem (2009) 1.08
Regulation of CDK4. Cell Div (2006) 1.06
Loss of Rpt5 protein interactions with the core particle and Nas2 protein causes the formation of faulty proteasomes that are inhibited by Ecm29 protein. J Biol Chem (2011) 1.01
Identification and functional analysis of a novel cyclin e/cdk2 substrate ankrd17. J Biol Chem (2009) 0.97
LBH589 Inhibits proliferation and metastasis of hepatocellular carcinoma via inhibition of gankyrin/STAT3/Akt pathway. Mol Cancer (2013) 0.94
Assembly manual for the proteasome regulatory particle: the first draft. Biochem Soc Trans (2010) 0.91
Evidence that proteasome-dependent degradation of the retinoblastoma protein in cells lacking A-type lamins occurs independently of gankyrin and MDM2. PLoS One (2007) 0.91
Dissection of protein-protein interaction and CDK4 inhibition in the oncogenic versus tumor suppressing functions of gankyrin and P16. J Mol Biol (2007) 0.88
The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling. Cell Res (2011) 0.88
Factor inhibiting HIF (FIH) recognizes distinct molecular features within hypoxia-inducible factor-α (HIF-α) versus ankyrin repeat substrates. J Biol Chem (2012) 0.84
Gankyrin is a predictive and oncogenic factor in well-differentiated and dedifferentiated liposarcoma. Oncotarget (2014) 0.79
Synthetic Proteins Potently and Selectively Bind the Oncoprotein Gankyrin, Modulate Its Interaction with S6 ATPase, and Suppress Gankyrin/MDM2-Dependent Ubiquitination of p53. ACS Chem Biol (2015) 0.77
Purification, crystallization and preliminary X-ray diffraction analysis of the non-ATPase subunit Nas6 in complex with the ATPase subunit Rpt3 of the 26S proteasome from Saccharomyces cerevisiae. Acta Crystallogr Sect F Struct Biol Cryst Commun (2007) 0.75
Inhibition of apoptosis by oncogenic hepatitis B virus X protein: Implications for the treatment of hepatocellular carcinoma. World J Hepatol (2016) 0.75
Gankyrin as a potential therapeutic target for cancer. Invest New Drugs (2017) 0.75
Gankyrin induces STAT3 activation in tumour microenvironment and sorafenib resistance in hepatocellular carcinoma. Cancer Sci (2017) 0.75
De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature (2004) 12.41
Ubiquitin and ubiquitin-like proteins as multifunctional signals. Nat Rev Mol Cell Biol (2005) 4.88
A double-hexameric MCM2-7 complex is loaded onto origin DNA during licensing of eukaryotic DNA replication. Proc Natl Acad Sci U S A (2009) 3.68
Increased islet apoptosis in Pdx1+/- mice. J Clin Invest (2003) 2.91
Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat Rev Drug Discov (2010) 2.90
Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood (2004) 2.72
Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem (2003) 2.44
An ORC/Cdc6/MCM2-7 complex is formed in a multistep reaction to serve as a platform for MCM double-hexamer assembly. Mol Cell (2013) 1.94
Cold-inducible RNA-binding protein modulates circadian gene expression posttranscriptionally. Science (2012) 1.91
The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell (2005) 1.90
Invited review: Effects of heat and cold stress on mammalian gene expression. J Appl Physiol (1985) (2002) 1.86
Depletion of 26S proteasomes in mouse brain neurons causes neurodegeneration and Lewy-like inclusions resembling human pale bodies. J Neurosci (2008) 1.79
Caspase activation inhibits proteasome function during apoptosis. Mol Cell (2004) 1.78
Fission yeast COP9/signalosome suppresses cullin activity through recruitment of the deubiquitylating enzyme Ubp12p. Mol Cell (2003) 1.72
Smc5-Smc6 mediate DNA double-strand-break repair by promoting sister-chromatid recombination. Nat Cell Biol (2006) 1.71
Purified cardiomyocytes from bone marrow mesenchymal stem cells produce stable intracardiac grafts in mice. Cardiovasc Res (2005) 1.70
CSN controls NF-kappaB by deubiquitinylation of IkappaBalpha. EMBO J (2007) 1.66
Oxygen-regulated expression of the RNA-binding proteins RBM3 and CIRP by a HIF-1-independent mechanism. J Cell Sci (2004) 1.62
Assembly, structure, and function of the 26S proteasome. Trends Cell Biol (2010) 1.61
The zinc finger of the CSN-associated deubiquitinating enzyme USP15 is essential to rescue the E3 ligase Rbx1. Curr Biol (2005) 1.55
Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J (2003) 1.53
Bone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension. Chest (2005) 1.45
The COP9 signalosome: at the interface between signal transduction and ubiquitin-dependent proteolysis. J Cell Sci (2002) 1.44
Heat shock protein A4 controls cell migration and gastric ulcer healing. Dig Dis Sci (2015) 1.42
Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest (2004) 1.31
The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage. Cancer Cell (2012) 1.30
Consequences of COP9 signalosome and 26S proteasome interaction. FEBS J (2005) 1.24
Conservation of the COP9/signalosome in budding yeast. BMC Genet (2002) 1.18
Recruitment of bone marrow-derived endothelial cells to sites of pancreatic beta-cell injury. Diabetes (2004) 1.18
Gankyrin: a new oncoprotein and regulator of pRb and p53. Trends Cell Biol (2006) 1.17
MAGE-A4 interacts with the liver oncoprotein gankyrin and suppresses its tumorigenic activity. J Biol Chem (2003) 1.15
The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53. J Biol Chem (2003) 1.14
Cirp protects against tumor necrosis factor-alpha-induced apoptosis via activation of extracellular signal-regulated kinase. Biochim Biophys Acta (2006) 1.13
The COP9 signalosome mediates beta-catenin degradation by deneddylation and blocks adenomatous polyposis coli destruction via USP15. J Mol Biol (2009) 1.13
Human immunodeficiency virus-1 Tat protein interacts with distinct proteasomal alpha and beta subunits. FEBS Lett (2003) 1.12
Bone marrow derived cells are involved in the pathogenesis of cardiac hypertrophy in response to pressure overload. Circulation (2007) 1.10
A novel protein overexpressed in hepatoma accelerates export of NF-kappa B from the nucleus and inhibits p53-dependent apoptosis. Cancer Cell (2002) 1.08
Ubiquitin-dependent degradation of Id1 and Id3 is mediated by the COP9 signalosome. J Mol Biol (2004) 1.07
Mesenchymal, but not hematopoietic, stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction in mice. Kidney Int (2005) 1.05
Cdc34 C-terminal tail phosphorylation regulates Skp1/cullin/F-box (SCF)-mediated ubiquitination and cell cycle progression. Biochem J (2007) 1.04
Association of gankyrin protein expression with early clinical stages and insulin-like growth factor-binding protein 5 expression in human hepatocellular carcinoma. Hepatology (2008) 1.04
The oncoprotein gankyrin negatively regulates both p53 and RB by enhancing proteasomal degradation. Cell Cycle (2005) 1.02
Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability. BMC Biochem (2007) 0.99
The LIMD1 protein bridges an association between the prolyl hydroxylases and VHL to repress HIF-1 activity. Nat Cell Biol (2012) 0.99
MDM2 is a novel E3 ligase for HIV-1 Vif. Retrovirology (2009) 0.98
Gankyrin oncoprotein overexpression as a critical factor for tumor growth in human esophageal squamous cell carcinoma and its clinical significance. Int J Cancer (2008) 0.98
Cold-inducible RNA-binding protein (Cirp) interacts with Dyrk1b/Mirk and promotes proliferation of immature male germ cells in mice. Proc Natl Acad Sci U S A (2012) 0.98
Apg-2 has a chaperone-like activity similar to Hsp110 and is overexpressed in hepatocellular carcinomas. FEBS Lett (2004) 0.97
Expression of cold-inducible RNA-binding protein in the normal endometrium, endometrial hyperplasia, and endometrial carcinoma. Int J Gynecol Pathol (2003) 0.97
COP9 signalosome function in the DDR. FEBS Lett (2011) 0.96
Ubiquitin-dependent proteolysis of the microtubule end-binding protein 1, EB1, is controlled by the COP9 signalosome: possible consequences for microtubule filament stability. J Mol Biol (2007) 0.96
The RTP site shared by the HIV-1 Tat protein and the 11S regulator subunit alpha is crucial for their effects on proteasome function including antigen processing. J Mol Biol (2002) 0.96
A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells. J Biol Chem (2004) 0.95
Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension. PLoS One (2012) 0.95
PEP-19 overexpression in human uterine leiomyoma. Mol Hum Reprod (2003) 0.95
Dose-dependent differential regulation of cytokine secretion from macrophages by fractalkine. J Immunol (2007) 0.95
The ubiquitin-proteasome system and cancer. Essays Biochem (2005) 0.94
Ouabain suppresses glucose-induced mitochondrial ATP production and insulin release by generating reactive oxygen species in pancreatic islets. Diabetes (2002) 0.94
The ubiquitin-proteasome pathway of intracellular proteolysis. Essays Biochem (2002) 0.93
Deleterious effect of the IL-23/IL-17A axis and γδT cells on left ventricular remodeling after myocardial infarction. J Am Heart Assoc (2012) 0.92
Increased expression of calcium-binding protein S100 in human uterine smooth muscle tumours. Mol Hum Reprod (2004) 0.92
Synthesis, structural and biological studies of ubiquitin mutants containing (2S, 4S)-5-fluoroleucine residues strategically placed in the hydrophobic core. Chembiochem (2003) 0.92
Low temperature protects mammalian cells from apoptosis initiated by various stimuli in vitro. Exp Cell Res (2005) 0.91
Enhanced deacetylation of p53 by the anti-apoptotic protein HSCO in association with histone deacetylase 1. J Biol Chem (2007) 0.90
Identification of a novel enhancer that binds Sp1 and contributes to induction of cold-inducible RNA-binding protein (cirp) expression in mammalian cells. BMC Biotechnol (2012) 0.90
Wnt2 accelerates cardiac myocyte differentiation from ES-cell derived mesodermal cells via non-canonical pathway. J Mol Cell Cardiol (2011) 0.90
Cold-inducible RNA-binding protein promotes the development of liver cancer. Cancer Sci (2015) 0.89
Intracellular IL-1 receptor antagonist type 1 inhibits IL-1-induced cytokine production in keratinocytes through binding to the third component of the COP9 signalosome. J Immunol (2005) 0.89
Human feeder cell line for derivation and culture of hESc/hiPSc. Stem Cell Res (2011) 0.89
Is malfunction of the ubiquitin proteasome system the primary cause of alpha-synucleinopathies and other chronic human neurodegenerative disease? Biochim Biophys Acta (2008) 0.88
[In vitro susceptibilities to levofloxacin and various antibacterial agents of 12,919 clinical isolates obtained from 72 centers in 2007]. Jpn J Antibiot (2009) 0.88
Role of a novel oncogenic protein, gankyrin, in hepatocyte proliferation. J Gastroenterol (2003) 0.88
Control of Deneddylation by the COP9 Signalosome. Subcell Biochem (2010) 0.88
Secreted frizzled related protein 1 is overexpressed in uterine leiomyomas, associated with a high estrogenic environment and unrelated to proliferative activity. J Clin Endocrinol Metab (2002) 0.88
The tumor-suppressive reagent taurolidine is an inhibitor of protein biosynthesis. Int J Cancer (2004) 0.87
[Evaluation of conversion gastrectomy for treatment of Stage IV advanced gastric cancer]. Gan To Kagaku Ryoho (2013) 0.87
The alpha4 and alpha7 subunits and assembly of the 20S proteasome. FEBS Lett (2004) 0.87